Hypoglycemia Associated With Congenital Hyperinsulinism clinical trials

Explore recruiting hypoglycemia associated with congenital hyperinsulinism clinical trials.

Also recruiting in Europe

Hypoglycemia Associated With Congenital Hyperinsulinism trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy and Safety of RZ358 in Patients with Congenital Hyperinsulinism

Denmark, Spain, Greece, Bulgaria, France, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Hypoglycemia Associated With Congenital Hyperinsulinism trials by city

Hypoglycemia Associated With Congenital Hyperinsulinism in Toronto Hypoglycemia Associated With Congenital Hyperinsulinism in Vancouver Hypoglycemia Associated With Congenital Hyperinsulinism in Montreal Hypoglycemia Associated With Congenital Hyperinsulinism in Calgary Hypoglycemia Associated With Congenital Hyperinsulinism in Edmonton Hypoglycemia Associated With Congenital Hyperinsulinism in Ottawa Hypoglycemia Associated With Congenital Hyperinsulinism in Winnipeg Hypoglycemia Associated With Congenital Hyperinsulinism in Quebec City Hypoglycemia Associated With Congenital Hyperinsulinism in Hamilton Hypoglycemia Associated With Congenital Hyperinsulinism in Kitchener Hypoglycemia Associated With Congenital Hyperinsulinism in London Hypoglycemia Associated With Congenital Hyperinsulinism in Halifax Hypoglycemia Associated With Congenital Hyperinsulinism in New York Hypoglycemia Associated With Congenital Hyperinsulinism in Los Angeles Hypoglycemia Associated With Congenital Hyperinsulinism in Chicago Hypoglycemia Associated With Congenital Hyperinsulinism in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease